FEB 19, 2016 8:59 AM PST

How Does Smoking Protect You From Parkinson's Disease?

WRITTEN BY: Cassidy Reich
Approximately one million people in the U.S. have Parkinson’s Disease (PD), a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in a brain region called the substantia nigra. While certain drugs and treatments, like L-DOPA and deep brain stimulation, can alleviate the motor symptoms of PD, there are no therapies that can slow down disease progression. The primary symptoms of PD are related to motor control, such as tremors and difficulty initiating voluntary movements, but there are many other nonmotor symptoms associated with this complex disease. Depression, sleep issues, and, as the disease progresses, dementia are also symptoms of PD.
 

Similar to Alzheimer’s, the majority of PD cases are sporadic, with no inherited genetic cause. Even though researchers don’t know exactly what causes PD, epidemiological studies over the past 60 years have revealed a crazy correlation between smoking and risk of PD.

Smoking cigarettes, a habit that everyone agrees is terrible for your health, can reduce your risk of developing PD by about 2-fold.

Why is this the case? Over 50 epidemiological studies have been done, and we know it’s not because people who smoke don’t live long enough to develop PD. Nicotine has actually be shown to be neuroprotective against PD, making this observation causative, not just correlational.
Nicotine binds nicotinic acetylcholine receptors (nAChRs) that are located presynaptically on dopaminergic neurons to stimulate dopamine release. And by binding to nAChRs, nicotine also causes Ca2+ influx into the neuron which could elicit more neuroprotective gene expression through a second messenger signaling cascade.
 
However, a recent paper published in The Journal of Neuroscience details a very physiological,”inside out” mechanism of neuroprotection. The experiments in this paper were done on cultured dopaminergic neurons and they used a very interesting model of PD. Since PD is a progressive disorder that occurs over many years, the researchers used a model of sustained endoplasmic reticulum (ER) stress like you would see in the early stages of disease progression instead of outright cell death. The concentration of nicotine used, 200 nM, is also significant because it is below the concentration needed to activate the nAChRs that are located on dopaminergic neurons. Nicotine is actually capable of diffusing through the cell membrane to reach the intracellular organelles, like the ER. Basically, this study showed that chronic nicotine exposure, at levels too low to activate most nAChRs, attenuated the ER stress and also suppressed the pro-apoptotic unfolded protein response (UPR) pathway through a process called “pharmacological chaperoning”. The nicotine made dopaminergic neurons that looked like the early stages of PD healthy again.

This is most likely not the only way nicotine elicits neuroprotection against PD, but it is important to unravel the different pathways to find new targets for treatments. And because nicotine has been shown to be neuroprotective, these pathways could offer a means of preventing disease onset.

Sources: NIH and Journal of Neuroscience
About the Author
  • Cassidy is a curious person, and her curiosity has led her to pursue a PhD in Pharmacology at the New York University Sackler Institute of Biomedical Sciences. She likes to talk about science way too much, so now she's going to try writing about it.
You May Also Like
APR 21, 2020
Immunology
A Nasal Vaccine Against Tau Tangles
APR 21, 2020
A Nasal Vaccine Against Tau Tangles
  One of the hallmarks of Alzheimer’s disease (AD) is the accumulation of “tau tangles”. Tau is a ...
APR 30, 2020
Cardiology
Nighttime Blood Pressure Changes Linked to Cerebrovascular Disease and Impaired Cognition
APR 30, 2020
Nighttime Blood Pressure Changes Linked to Cerebrovascular Disease and Impaired Cognition
When most people go to sleep, their blood pressure decreases, or dips, compared to daytime values. However, for some, a ...
MAY 22, 2020
Neuroscience
Diesel Fumes Increase Risk for Developing Parkinson's
MAY 22, 2020
Diesel Fumes Increase Risk for Developing Parkinson's
Around 10 million people worldwide have Parkinson's disease, a progressive nervous system disorder that affects move ...
MAY 25, 2020
Genetics & Genomics
FDA Approves the First Treatment for Neurofibromatosis 1
MAY 25, 2020
FDA Approves the First Treatment for Neurofibromatosis 1
In a major breakthrough, the Food and Drug Administration has approved a treatment for a genetic disorder called neurofi ...
JUN 18, 2020
Neuroscience
Living Environment Correlated with Living to 100
JUN 18, 2020
Living Environment Correlated with Living to 100
Researchers from Washington State University have found that where you live may predict how long you will live. In a stu ...
JUN 23, 2020
Health & Medicine
New Evidence Medical Cannabis Can Lead to Decreased Opioid Use in Chronic Pain
JUN 23, 2020
New Evidence Medical Cannabis Can Lead to Decreased Opioid Use in Chronic Pain
For people with long term ongoing pain, medical cannabis is a valid option that could pave the way to reduced use of opi ...
Loading Comments...